FDA Drug Recalls

Recalls / Class III

Class IIID-1094-2017

Product

Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12

Affected lot / code info
Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018

Why it was recalled

Failed impurities/degradation specifications: Out of specification for a related compound C.

Recalling firm

Firm
AVKARE Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
615 N 1st St, N/A, Pulaski, Tennessee 38478-2403

Distribution

Quantity
1172 cartons (23440 tablets)
Distribution pattern
Nationwide

Timeline

Recall initiated
2017-07-19
FDA classified
2017-08-15
Posted by FDA
2017-08-23
Terminated
2019-03-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1094-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls